Testosterone cypionate Clinical Trials
4 recruitingDrug
Phase 24
Showing 1–4 of 4 trials
Recruiting
Phase 2
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
Castration Resistant Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins150 enrolled6 locationsNCT04363164
Recruiting
Phase 2
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Metastatic Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins60 enrolled1 locationNCT07142551
Recruiting
Phase 2
The COSMYC Trial (COmbined Suppression of MYC)
Metastatic Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins50 enrolled1 locationNCT06922318
Recruiting
Phase 2
The Anabolic Effect of Testosterone on Pelvic Floor Muscles
MenopauseStress Urinary Incontinence
Brigham and Women's Hospital30 enrolled1 locationNCT06111209